Related references
Note: Only part of the references are listed.Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
Laura Elisa Buitrago-Molina et al.
JOURNAL OF AUTOIMMUNITY (2021)
Regulatory T cells in autoimmune hepatitis: an updated overview
Maria Serena Longhi et al.
JOURNAL OF AUTOIMMUNITY (2021)
Established and novel therapeutic options for autoimmune hepatitis
Rodrigo Liberal et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack et al.
HEPATOLOGY (2020)
Normalization of serum immunoglobulin G levels is associated with improved transplant -free survival in patients with autoimmune hepatitis
Alessio Gerussi et al.
DIGESTIVE AND LIVER DISEASE (2020)
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
Simon Pape et al.
LIVER INTERNATIONAL (2020)
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group
Ansgar W. Lohse et al.
JOURNAL OF HEPATOLOGY (2020)
Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis
Stuart K. Roberts et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
Treatment of primary Sjogren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
Thomas Doerner et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis
Albert J. Czaja
AUTOIMMUNITY (2019)
Adverse events related to low dose corticosteroids in autoimmune hepatitis
Floris F. van den Brand et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine
Silvia Nastasio et al.
DIGESTIVE AND LIVER DISEASE (2019)
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine
Georgios Giannakopoulos et al.
DIGESTIVE AND LIVER DISEASE (2019)
Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis
Priscila Santiago et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
Nwe Ni Than et al.
JHEP REPORTS (2019)
Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis
Clemence Legue et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis
Moritz Peiseler et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis
Tiong Y. Lim et al.
HEPATOLOGY (2018)
Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement
Giorgina Mieli-Vergani et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Real-world management of juvenile autoimmune liver disease
Y. S. de Boer et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands
Floris F. van den Brand et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Targeting IL-2: an unexpected effect in treating immunological diseases
Congxiu Ye et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune Hepatitis
Christopher B. O'Brien et al.
HEPATOLOGY COMMUNICATIONS (2018)
Expert clinical management of autoimmune hepatitis in the real world
R. Liberal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
The use of tacrolimus in refractory autoimmune hepatitis in children and adults: a single center experience
Haider Al Taii et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
JKB-122 is effective, alone or in combination with prednisolone in Con A-induced hepatitis
Mei-Chi Hsu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Regulatory T-Cell Conditioning Endows Activated Effector T Cells With Suppressor Function in Autoimmune Hepatitis/Autoimmune Sclerosing Cholangitis
Rodrigo Liberal et al.
HEPATOLOGY (2017)
Generation of human islet-specific regulatory T cells by TCR gene transfer
Caroline M. Hull et al.
JOURNAL OF AUTOIMMUNITY (2017)
Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy
Jana Diestelhorst et al.
PLOS ONE (2017)
Autoimmune hepatitis: standard treatment and systematic review of alternative treatments
Benedetta Terziroli Beretta-Piccoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
PIF* promotes brain re-myelination locally while regulating systemic inflammation-clinically relevant multiple sclerosis M.smegmatis model
Giuseppe Migliara et al.
ONCOTARGET (2017)
Immunosuppressive drugs affect interferon (IFN)- and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis
C. R. Grant et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases
H. C. Jeffery et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Rituximab: 13 open questions after 20 years of clinical use
Francesca Pavanello et al.
CANCER TREATMENT REVIEWS (2017)
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy
Nwe Ni Than et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis
K. Zachou et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
X. Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
Sina Huebener et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Refractory Autoimmune Hepatitis: Beyond Standard Therapy
Jonah N. Rubin et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
A Pilot Study of Operational Tolerance With a Regulatory T-cell-Based Cell Therapy in Living Donor Liver Transplantation
Satoru Todo et al.
HEPATOLOGY (2016)
CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease
Rodrigo Liberal et al.
JOURNAL OF AUTOIMMUNITY (2016)
B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis
Hiroki Nishikawa et al.
MEDICINE (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Corticosteroids Mechanisms of Action in Health and Disease
Sivapriya Ramamoorthy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Christoph T. Ellebrecht et al.
SCIENCE (2016)
Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review
Berrie Meijer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease
Jeffrey A. Bluestone et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression
Rodrigo Liberal et al.
HEPATOLOGY (2015)
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells
Charles J. M. Bell et al.
JOURNAL OF AUTOIMMUNITY (2015)
Autoimmune hepatitis - Update 2015
Michael P. Manns et al.
JOURNAL OF HEPATOLOGY (2015)
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis
Johannes Hartl et al.
JOURNAL OF HEPATOLOGY (2015)
EASL Clinical Practice Guidelines: Autoimmune hepatitis
JOURNAL OF HEPATOLOGY (2015)
Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use
Henriette Ytting et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases
Susana Rodrigues et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Use of Sirolimus in the Treatment of Refractory Autoimmune Hepatitis
Hemant Chatrath et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Infliximab Leading to Autoimmune Hepatitis: An Increasingly Recognized Side Effect
Bulent Yilmaz et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Role of α-lipoic acid in LPS/D-GalN induced fulminant hepatic failure in mice: Studies on oxidative stress, inflammation and apoptosis
Xiaomin Xia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies
Richard Taubert et al.
JOURNAL OF HEPATOLOGY (2014)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells
Dan Blat et al.
MOLECULAR THERAPY (2014)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
Regulatory T cells as immunotherapy
Benjamin D. Singer et al.
FRONTIERS IN IMMUNOLOGY (2014)
Role of Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis-An Observational Study
Dinesh Jothimani et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Letter: allopurinol co-therapy is safe and effective in autoimmune hepatitis
S. Al-Shamma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
N. A. Kennedy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis
Y. S. de Boer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)
Yehudith Azar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy
Kelly W. Burak et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
New Insights into the Anti-inflammatory Mechanisms of Glucocorticoids: An Emerging Role for Glucocorticoid-Receptor-Mediated Transactivation
Sofie Vandevyver et al.
ENDOCRINOLOGY (2013)
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission
Nicole M. F. van Gerven et al.
JOURNAL OF HEPATOLOGY (2013)
Infliximab as rescue therapy in paediatric autoimmune hepatitis
Jeremy Rajanayagam et al.
JOURNAL OF HEPATOLOGY (2013)
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
Christina Weiler-Normann et al.
JOURNAL OF HEPATOLOGY (2013)
Calcineurin Inhibitors: 40 Years Later, Can't Live Without
Jamil R. Azzi et al.
JOURNAL OF IMMUNOLOGY (2013)
Budesonide for Juvenile Autoimmune Hepatitis? Not Yet
Giorgina Mieli-Vergani et al.
JOURNAL OF PEDIATRICS (2013)
Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents
Marek Woynarowski et al.
JOURNAL OF PEDIATRICS (2013)
Successful Treatment of Refractory Autoimmune Hepatitis With Rituximab
Daniel D'Agostino et al.
PEDIATRICS (2013)
CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
Laura Passerini et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis
Joanna Ramirez Marlaka et al.
ACTA PAEDIATRICA (2012)
Cutting Edge Issues in Autoimmune Hepatitis
Diego Vergani et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Inhibition of Interleukin-17 Promotes Differentiation of CD25- Cells Into Stable T Regulatory Cells in Patients With Autoimmune Hepatitis
Maria Serena Longhi et al.
GASTROENTEROLOGY (2012)
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway
Rodrigo Liberal et al.
HEPATOLOGY (2012)
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis
Harpreet K. Dhaliwal et al.
HEPATOLOGY (2012)
Adult-onset Still's Disease Complicated by Autoimmune Hepatitis: Successful Treatment with Infliximab
Kenji Fujii et al.
INTERNAL MEDICINE (2012)
FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Moritz Peiseler et al.
JOURNAL OF HEPATOLOGY (2012)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Preimplantation Factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model
Lola Weiss et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms
Ling Yang et al.
FRONTIERS IN PHYSIOLOGY (2012)
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes
A. M. C. Baven-Pronk et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience
M. M. Tannous et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Pregnancy outcome in women with autoimmune hepatitis
Neelam Aggarwal et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
Pathogenesis of autoimmune hepatitis
Rodrigo Liberal et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Autoantigen-Specific Regulatory T Cells, a Potential Tool for Immune-Tolerance Reconstitution in Type-2 Autoimmune Hepatitis
Maria Serena Longhi et al.
HEPATOLOGY (2011)
Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients
Kalliopi Zachou et al.
JOURNAL OF HEPATOLOGY (2011)
Autoimmune hepatitis
Ansgar W. Lohse et al.
JOURNAL OF HEPATOLOGY (2011)
Autoimmune hepatitis
Giorgina Mieli-Vergani et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome
Elizabeth J. Carey et al.
REVISTA MEDICA DE CHILE (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice
Lola Weiss et al.
ENDOCRINE (2011)
Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn's Disease with no Relapse After Switching to Adalimumab
Marilia Cravo et al.
BIODRUGS (2010)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy
Kaveh Sharzehi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
Michael P. Manns et al.
GASTROENTEROLOGY (2010)
A Multifaceted Imbalance of T Cells with Regulatory Function Characterizes Type 1 Autoimmune Hepatitis
Silvia Ferri et al.
HEPATOLOGY (2010)
Toll-like Receptor 4 and Hepatic Fibrogenesis
Jean-Philippe Pradere et al.
SEMINARS IN LIVER DISEASE (2010)
Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
A Case of Difficult-to-Treat Autoimmune Hepatitis Successfully Managed by TNF-α Blockade
Christina Weiler-Normann et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Vigorous Activation of Monocytes in Juvenile Autoimmune Liver Disease Escapes the Control of Regulatory T-Cells
Maria Serena Longhi et al.
HEPATOLOGY (2009)
Follow-up of Pregnant Women With Autoimmune Hepatitis The Disease Behavior Along With Maternal and Fetal Outcomes
Debora Raquel B. Terrabuio et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis
Graham P. Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Elke M. Hennes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The use of budesonide in the treatment of autoimmune hepatitis in Canada
Iman Zandieh et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis
Jonathan T. Hlivko et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
Mark R. Hutchinson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Safety issues in the management of autoimmune hepatitis
Albert J. Czaja
EXPERT OPINION ON DRUG SAFETY (2008)
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis
Maria Serena Longhi et al.
HEPATOLOGY (2008)
Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis
Joshua T. Evans et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
Julia Yuen-Shan Tsang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis
Gerard Ozorio et al.
MEDICAL JOURNAL OF AUSTRALIA (2007)
Pregnancy outcome of women exposed to azathioprine during pregnancy
Lee Hilary Goldstein et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2007)
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2
Maria Serena Longhi et al.
HEPATOLOGY (2007)
Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases
Manuel Ramos-Casals et al.
MEDICINE (2007)
Elevated serum BAFF levels in patients with autoimmune hepatitis
Kiyoshi Migita et al.
HUMAN IMMUNOLOGY (2007)
Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy
Ira Inductivo-Yu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis
Fin Stolze Larsen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Follow-up of children with autoimmune hepatitis treated with cyclosporine
Miriam Cuarterolo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis
Michael A. Heneghan et al.
JOURNAL OF HEPATOLOGY (2006)
Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis
Sanjoy Banerjee et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Azathioprine use during pregnancy: Unexpected intrauterine exposure to metabolites
NKH de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis
Maria Serena Longhi et al.
JOURNAL OF IMMUNOLOGY (2006)
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2
Y Ma et al.
GASTROENTEROLOGY (2006)
Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature
Edgardo S. Santos et al.
LIVER INTERNATIONAL (2006)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil - Comparison with conventional treatment for refractory disease
AJ Czaja et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis
MS Longhi et al.
JOURNAL OF AUTOIMMUNITY (2005)
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
N Chatur et al.
LIVER INTERNATIONAL (2005)
Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine
NKH de Boer et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Cutting edge:: Contact-mediated suppression by CD4+-CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism
DC Gondek et al.
JOURNAL OF IMMUNOLOGY (2005)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
SM Devlin et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis
BA Aqel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
MS Longhi et al.
JOURNAL OF HEPATOLOGY (2004)
Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease - a possible target for infliximab treatment
J Agnholt et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
BAFF: A fundamental survival factor for B cells
F Mackay et al.
NATURE REVIEWS IMMUNOLOGY (2002)
CTLA-4/CD28 region polymorphisms in children from families with autoimmune hepatitis
I Djilali-Saiah et al.
HUMAN IMMUNOLOGY (2001)
Control of T-cell activation by CD4+ CD25+ suppressor T cells
EM Shevach et al.
IMMUNOLOGICAL REVIEWS (2001)
Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis
R Malekzadeh et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Long-term management and prognosis of autoimmune hepatitis (AIH):: A single center experience
S Kanzler et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2001)
Management and outcome of pregnancy in autoimmune hepatitis
MA Heneghan et al.
GUT (2001)
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
AJ Czaja et al.
GASTROENTEROLOGY (2000)
Share Paper
